BioSphere Medical, Inc. (BSMD) news stock charts
BioSphere Medical, Inc. (BSMD) Investment Summary:
We develop, manufacture and market products for medical procedures that use embolotherapy. Embolotherapy is the therapeutic introduction of various biocompatible substances into a patient's circulatory system to occlude a blood vessel, either to arrest or prevent hemorrhaging, or to devitalize or destroy the structure or organ by occluding its blood supply. Our core technologies consist of patented bioengineered polymers, which are chemical compounds that we create through the application of medical science, engineering principles and manufacturing methods. These core technologies are used to produce miniature spherical embolic particles, or microspheres, that are designed to have uniquely beneficial properties for a variety of medical applications. Our pioneering embolic products, Embosphere® Microspheres and EmboGold® Microspheres, have a number of beneficial properties that we believe make them well suited for embolotherapy procedures. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f26%2f0001047469-08-003451.html#FIS_BUSINESS"www.biospheremed.com
Founded in 1993
BIOSPHERE MEDICAL INC (BSMD:NASDAQ)
LAST $3.00 USD
CHANGE TODAY +0.0501 1.70%
VOLUME 8.7K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of BIOSPHERE MEDICAL INC (BSMD)
|
OPEN
$2.95
|
PREVIOUS CLOSE
$2.95
|
|
|
DAY HIGH
$3.00
|
DAY LOW
$2.95
|
|
|
52 WEEK HIGH
09/9/09 - $4.19
|
52 WEEK LOW
05/1/09 - $1.26
|
|
|
MARKET CAP
55.2M
|
AVERAGE VOLUME 10 D
20.0K
|
|
|
EPS TTM
$-0.18
|
SHARES OUTSTANDING
18.4M
|
|
|
BSMD Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for BIOSPHERE MEDICAL INC (BSMD)
BioSphere Medical Inc., Annual General Meeting, May 17, 2010
03/2/2010
BioSphere Medical Inc., Annual General Meeting, May 17, 2010
BioSphere Medical Inc. expected to Report Q1 2010 Results on April 26, 2010. This event was calculated by Capital IQ (Created on February 17, 2010).
02/17/2010
BioSphere Medical Inc. expected to Report Q1 2010 Results on April 26, 2010. This event was calculated by Capital IQ (Created on February 17, 2010).
Biosphere Medical, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2009
02/10/2010
BioSphere Medical Inc. reported financial results for the three and 12 months ended December 31, 2009. Total worldwide revenue for the fourth quarter of 2009 was $8.36 million, an increase of 16%, compared with $7.24 million for the fourth quarter of 2008. Operating loss for the fourth quarter of 2009 declined significantly, to $0.49 million from $1.58 million in the same period of 2008, a drop of 69%. Net loss applicable to common stockholders in the fourth quarter of 2009 was $0.44 million, or $0.02 per share, improved 74% compared with a net loss applicable to common stockholders in the same period last year of $1.68 million, or $0.09 per share. Net loss before tax was $346,000 against $1.5 million for the same period in 2008. For the year ended December 31, 2009, total revenue was $31.44 million, compared with $29.26 million in the prior-year period, an increase of 7%. Full-year 2008 revenue includes $0.82 million of phased-out gastric product revenue. Net loss applicable to common stockholders in 2009 was $3.25 million, or $0.18 per share, compared with $6.07 million, or $0.34 per share, in 2008. Operating loss was $3.4 million against $5.8 million for the same period in 2008. Net loss before tax was $3.3 million against $5.4 million for the same period in 2008.
BioSphere Medical, Inc. financial resources
BSMD Competitors
| Company | Last | Change |
| Angiodynamics Inc | $15.40 USD | -0.25 |
| Biocompatibles International PLC | 234.00 GBp | -0.50 |
| CR Bard Inc | $83.82 USD | -0.43 |
| Diomed Holdings Inc | $0.0020 USD | 0.00 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | BSMD | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 1.7x |
|
| Price/Book | 2.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.2x |
|
|
BSMD |
||
|
BSMD transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About BioSphere Medical, Inc.
BIOSPHERE MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
2010-03-16 08:02:50
Quote: Item 7.01.Regulation FD Disclosure.
BioSphere Medical, Inc. (the "Company") is hereby furnishing the corporate
presentation (the "Presentation") that it intends to provide to investors and
other third parties from time to time as part of its investor relations
activities, including in meetings being held in Dana Point, California on
March 15, 2010 at the Roth Capital Partners 22 Annual OC Growth Stock
Conference.A copy of the Presentation is attached as Exhibit 99.1 to this
...Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi
2010-03-15 03:05:05
Quote: Item 1.01.Entry into a Material Definitive Agreement.
Lease Amendment
On March 9, 2010, BioSphere Medical, Inc. ("BioSphere") entered into a Fifth
Amendment to Lease (the "Lease Amendment") with John H. Spurr, Jr. and William
G. Constable (Successor to Thomas J. Teuten), Trustees of 1050 Hingham Street
Realty Trust ("Realty Trust").The Lease Amendment further amends the Lease,
dated January 7, 2000, as amended (the "Lease"), between BioSphere and Realty...Read article
BioSphere Medical, Inc. Earnings Call scheduled for 8:30 am ET today
2010-03-04 09:18:50
Quote: Call DetailsBioSphere Medical, Inc. Earnings Conference Call (Q4 2009)Thu,
Feb 11, 2010, 8:30 am EasternAbout BioSphere Medical, Inc.BSMD)BioSphere Medical, Inc. develops, manufactures, and markets products for medical procedures that use embolotherapy. The company focuses on the treatment of symptomatic uterine fibroids, which are noncancerous, or benign, hypervascular tumors growing within or on the wall of the uterus, using a procedure called uterine fibroid embolization. Its microsphere prod...Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers
2010-03-03 07:38:52
Quote: Item 5.02.Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
(e)On February 24, 2010, the Compensation Committee of the Board of
Directors of BioSphere Medical, Inc. (the "Company") approved an 8% increase in
the annual base salary of Melodie R. Domurad, the Company's Vice President of
Regulatory, Medical Affairs and Quality Systems.Ms. Domurad's annual base
salary for the fiscal year endi...Read article
BioSphere Medical to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference
2010-03-03 07:38:52
Quote: Areplay of the webcast will be available at the Company's Web site for 30days following the presentation.About BioSphere Medical, Inc.BioSphere Medical, Inc. seeks to pioneer and commercialize minimallyinvasive diagnostic and therapeutic applications based on proprietarybioengineered microsphere technology. The Company's core technologies,patented bioengineered polymers and manufacturing methods, are used toproduce microscopic spherical materials with unique beneficialproperties for a variety of...Read article
BioSphere Medical to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference
2010-03-02 06:06:17
Quote: Areplay of the webcast will be available at the Company's Web site for 30days following the presentation.About BioSphere Medical, Inc.BioSphere Medical, Inc. seeks to pioneer and commercialize minimallyinvasive diagnostic and therapeutic applications based on proprietarybioengineered microsphere technology. The Company's core technologies,patented bioengineered polymers and manufacturing methods, are used toproduce microscopic spherical materials with unique beneficialproperties for a variety of...Read article
BioSphere Medical Reports Fourth Quarter Revenue of $8.4 Million and a Narrowed Net Loss of $0.02 Per Share
2010-02-12 01:21:19
Quote: Read article
BioSphere Medical Reports Fourth Quarter Revenue of $8.4 Million and a Narrowed Net Loss of $0.02 Per Share
2010-02-11 04:28:22
Quote: Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
2010-02-11 04:28:21
Quote: Item 2.02.Results of Operations and Financial Condition.
On February 10, 2010, BioSphere Medical, Inc. announced its financial results
for the quarter ended December 31, 2009.The full text of the press release
issued in connection with the announcement is attached as Exhibit 99.1 to this
Current Report on Form 8-K.
The information in Item 2.02 and the Exhibit attached hereto shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the
"Exchan...Read article
BioSphere Medical Announces Retirement of William M. Cousins, Jr.
2010-02-03 03:48:33
Quote: We wish Bill the very best in his retirement,and it is with regret that we will accept his resignation fromBioSphere’s board of directors effective in May.â€About BioSphere Medical, Inc.BioSphere Medical, Inc. is the pioneer in the use of bioengineeredmicrospheres to treat uterine fibroids, hypervascularized tumors andvascular malformations by a minimally invasive, image-guided medicalprocedure called embolotherapy. The Company uses its core technologies,patented bioengineered polyme...Read article
BioSphere Medical Announces Retirement of William M. Cousins, Jr.
2010-02-02 01:13:52
Quote: We wish Bill the very best in his retirement,and it is with regret that we will accept his resignation fromBioSphere’s board of directors effective in May.â€About BioSphere Medical, Inc.BioSphere Medical, Inc. is the pioneer in the use of bioengineeredmicrospheres to treat uterine fibroids, hypervascularized tumors andvascular malformations by a minimally invasive, image-guided medicalprocedure called embolotherapy. The Company uses its core technologies,patented bioengineered polyme...Read article
BioSphere Medical Schedules Fourth Quarter 2009 Financial Results Conference Call February 11
2010-02-01 03:45:55
Quote: Easterntime to discuss these results.www.biospheremed.com.A replay of the webcast will also be available on BioSphere Medical’sWeb site.About BioSphere Medical, Inc.BioSphere Medical, Inc. seeks to pioneer and commercialize minimallyinvasive diagnostic and therapeutic applications based on proprietarybioengineered microsphere technology. The Company's core technologies,patented bioengineered polymers and manufacturing methods, are used toproduce microscopic spherical materials with unique...Read article
BioSphere Medical Schedules Fourth Quarter 2009 Financial Results Conference Call February 11
2010-01-29 04:01:23
Quote: Easterntime to discuss these results.www.biospheremed.com.A replay of the webcast will also be available on BioSphere Medical’sWeb site.About BioSphere Medical, Inc.BioSphere Medical, Inc. seeks to pioneer and commercialize minimallyinvasive diagnostic and therapeutic applications based on proprietarybioengineered microsphere technology. The Company's core technologies,patented bioengineered polymers and manufacturing methods, are used toproduce microscopic spherical materials with unique...Read article
BioSphere Medical to Present at the 12th Annual Needham Growth Stock Conference
2010-01-29 04:01:23
Quote: Areplay of the webcast will be available at the Company's Web site for 30days following the presentation.About BioSphere Medical, Inc.BioSphere Medical, Inc. seeks to pioneer and commercialize minimallyinvasive diagnostic and therapeutic applications based on proprietarybioengineered microsphere technology. The Company's core technologies,patented bioengineered polymers and manufacturing methods, are used toproduce microscopic spherical materials with unique beneficialproperties for a variety of...Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
2010-01-27 03:25:49
Quote: Item 2.02.Results of Operations and Financial Condition.
On July 29, 2009, BioSphere Medical, Inc. announced its financial results for
the quarter ended June 30, 2009.The full text of the press release issued in
connection with the announcement is attached as Exhibit 99.1 to this Current
Report on Form 8-K.
The information in Item 2.02 and the Exhibit attached hereto shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the
"Exchange Act&q...Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
2010-01-27 03:25:49
Quote: Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
2010-01-12 04:15:38
Quote: Item 7.01.Regulation FD Disclosure.
BioSphere Medical, Inc. (the "Company") is hereby furnishing the corporate
presentation (the "Presentation") that it intends to provide to investors and
other third parties from time to time as part of its investor relations
activities, including in meetings being held in San Francisco from
January 11-14, 2010 at the J.P. Morgan 28th Annual Healthcare Conference.A
copy of the Presentation is attached as Exhibit 99.1 to this Current Report ...Read article
BioSphere Medical to Present at the 12th Annual Needham Growth Stock Conference
2010-01-07 01:57:39
Quote: Areplay of the webcast will be available at the Company's Web site for 30days following the presentation.About BioSphere Medical, Inc.BioSphere Medical, Inc. seeks to pioneer and commercialize minimallyinvasive diagnostic and therapeutic applications based on proprietarybioengineered microsphere technology. The Company's core technologies,patented bioengineered polymers and manufacturing methods, are used toproduce microscopic spherical materials with unique beneficialproperties for a variety of...Read article
BIOSPHERE MEDICAL INC Files SEC form 10-Q, Quarterly Report
2010-01-06 04:27:11
Quote: As of June 30, 2009, the credits have been deferred and are included in
other accrued liabilities.
Although BioSphere Medical S.A., or BMSA, our wholly owned French subsidiary,
has been profitable in recent periods, we expect that BMSA will recognize a loss
in the current year, and, therefore, we will continue to maintain a full
valuation allowance on our tax benefits until profitability has been sustained
over a time period that is, and in amounts that are, sufficient to support a
conclusion th...Read article
BIOSPHERE MEDICAL INC Files SEC form 8-K, Other Events
2009-12-21 18:04:39
Quote: Item 8.01.Other Events.
On September 15, 2009, BioSphere Medical, Inc. ("BioSphere" or the "Company")
entered into a settlement agreement in the product liability lawsuit filed
against the Company and other previously-dismissed defendants on behalf of Brett
Pingel in state court in St. Louis, Missouri.Because the plaintiff is a minor,
the settlement agreement must receive court approval, which the Company expects
to occur within the next thirty to sixty days.Once approved by...Read article
Would you like to leave a comment about BioSphere Medical, Inc. BSMD
Find out what social network information about BioSphere Medical, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides BioSphere Medical, Inc.'s Stock there is more great penny stock and market information at Realpennies